HUP0003792A3 - Novel use of compounds for anti-pruritic activity - Google Patents
Novel use of compounds for anti-pruritic activityInfo
- Publication number
- HUP0003792A3 HUP0003792A3 HU0003792A HUP0003792A HUP0003792A3 HU P0003792 A3 HUP0003792 A3 HU P0003792A3 HU 0003792 A HU0003792 A HU 0003792A HU P0003792 A HUP0003792 A HU P0003792A HU P0003792 A3 HUP0003792 A3 HU P0003792A3
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- novel use
- pruritic activity
- pruritic
- activity
- Prior art date
Links
- 230000001139 anti-pruritic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6374697P | 1997-10-17 | 1997-10-17 | |
| PCT/US1998/021886 WO1999020280A1 (en) | 1997-10-17 | 1998-10-16 | Novel use of compounds for anti-pruritic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0003792A2 HUP0003792A2 (en) | 2001-10-28 |
| HUP0003792A3 true HUP0003792A3 (en) | 2001-12-28 |
Family
ID=22051225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0003792A HUP0003792A3 (en) | 1997-10-17 | 1998-10-16 | Novel use of compounds for anti-pruritic activity |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1030666A4 (en) |
| JP (1) | JP2001520196A (en) |
| KR (1) | KR20010031149A (en) |
| CN (1) | CN1306426A (en) |
| AR (1) | AR015966A1 (en) |
| AU (1) | AU740875B2 (en) |
| BR (1) | BR9814080A (en) |
| CA (1) | CA2306985A1 (en) |
| CO (1) | CO4810374A1 (en) |
| CZ (1) | CZ20001376A3 (en) |
| HU (1) | HUP0003792A3 (en) |
| IL (1) | IL135581A0 (en) |
| NO (1) | NO20001847D0 (en) |
| NZ (1) | NZ503551A (en) |
| PL (1) | PL341062A1 (en) |
| TR (1) | TR200001040T2 (en) |
| WO (1) | WO1999020280A1 (en) |
| ZA (1) | ZA989450B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| CA2436535A1 (en) | 2001-01-31 | 2002-08-08 | Prizer Products Inc. | Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| EE200300362A (en) | 2001-01-31 | 2003-12-15 | Pfizer Products Inc. | Thiazolyl, oxazolyl, pyrrolyl and imidazolylic acid amide derivatives used as inhibitors of PDE4 isozymes |
| HUP0302891A2 (en) | 2001-01-31 | 2003-12-29 | Pfizer Products Inc. | Ether derivatives useful as inhibitors of pde4 isozymes, their use and pharmaceutical compositions containing them |
| US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
| EP1647274A4 (en) * | 2003-07-17 | 2008-12-10 | Ono Pharmaceutical Co | Remedy for pruritus comprising piperidine derivative as the active ingredient |
| JP2005187458A (en) * | 2003-12-04 | 2005-07-14 | Santen Pharmaceut Co Ltd | Itchiness-treating agent consisting of cilomilast or its salt as active ingredient |
| WO2005053672A1 (en) * | 2003-12-04 | 2005-06-16 | Santen Pharmaceutical Co., Ltd. | Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient |
| WO2005077950A2 (en) | 2004-02-14 | 2005-08-25 | Smithkline Beecham Corporation | Medicaments with hm74a receptor activity |
| JP2008137892A (en) * | 2005-03-04 | 2008-06-19 | Eisai Co Ltd | Antipruritic agent |
| BRPI0614270A2 (en) | 2005-08-10 | 2011-03-22 | Smithkline Beecham Corp | xanthine derivatives as selective ha74a agonists |
| TWI404709B (en) * | 2006-02-21 | 2013-08-11 | Eisai R&D Man Co Ltd | 4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives |
| EP1992622B1 (en) * | 2006-02-21 | 2011-07-27 | Eisai R&D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative |
| EP2123641A4 (en) | 2007-02-16 | 2011-06-22 | Eisai R&D Man Co Ltd | Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid |
| CN102336717B (en) | 2007-08-17 | 2013-09-18 | 卫材R&D管理有限公司 | Quinazoline derivative |
| US8513269B2 (en) | 2007-08-17 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Preparation for external use |
| US20140121240A1 (en) | 2011-06-28 | 2014-05-01 | Maruho Co., Ltd. | Novel pharmaceutical composition |
| EA034139B1 (en) | 2015-01-30 | 2020-01-09 | Шаньтонь Фарма Ко., Лтд. | Prevention or treatment of uric acid or gout diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0563168B1 (en) * | 1990-12-21 | 2000-07-05 | Beecham Group Plc | Xanthine derivatives |
| ATE224386T1 (en) * | 1996-03-26 | 2002-10-15 | Altana Pharma Ag | NEW 6-POSITION SUBSTITUTED PHENANTHRIDINE |
| ES2187775T3 (en) * | 1996-05-15 | 2003-06-16 | Altana Pharma Ag | IMIDAZOPIRIDINS. |
| DE69817548T2 (en) * | 1997-03-07 | 2004-06-17 | Altana Pharma Ag | TETRAZOLE DERIVATIVES |
| PL336464A1 (en) * | 1997-03-18 | 2000-06-19 | Basf Ag | Method of and compositions for modulating reactivity in respect to corticosteroids i |
| WO1998055481A1 (en) * | 1997-06-03 | 1998-12-10 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
-
1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/en not_active Application Discontinuation
- 1998-10-16 PL PL98341062A patent/PL341062A1/en unknown
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/en not_active Application Discontinuation
- 1998-10-16 ZA ZA989450A patent/ZA989450B/en unknown
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/en unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/en unknown
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/en unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 CO CO98060225A patent/CO4810374A1/en unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/en not_active IP Right Cessation
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/en not_active Withdrawn
- 1998-10-16 CN CN98810066A patent/CN1306426A/en active Pending
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 IL IL13558198A patent/IL135581A0/en unknown
-
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL135581A0 (en) | 2001-05-20 |
| ZA989450B (en) | 1999-04-19 |
| AU740875B2 (en) | 2001-11-15 |
| TR200001040T2 (en) | 2001-01-22 |
| CA2306985A1 (en) | 1999-04-29 |
| KR20010031149A (en) | 2001-04-16 |
| AU1093899A (en) | 1999-05-10 |
| WO1999020280A1 (en) | 1999-04-29 |
| CZ20001376A3 (en) | 2002-06-12 |
| NZ503551A (en) | 2002-05-31 |
| CN1306426A (en) | 2001-08-01 |
| EP1030666A4 (en) | 2002-10-16 |
| BR9814080A (en) | 2000-09-26 |
| HUP0003792A2 (en) | 2001-10-28 |
| CO4810374A1 (en) | 1999-06-30 |
| NO20001847L (en) | 2000-04-10 |
| NO20001847D0 (en) | 2000-04-10 |
| AR015966A1 (en) | 2001-05-30 |
| EP1030666A1 (en) | 2000-08-30 |
| PL341062A1 (en) | 2001-03-26 |
| JP2001520196A (en) | 2001-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1025322A1 (en) | Novel spiroazabicyclic heterocyclic compounds | |
| HUP0003792A3 (en) | Novel use of compounds for anti-pruritic activity | |
| EG24177A (en) | Novel compounds | |
| CZ219999A3 (en) | Novel compounds exhibiting analgetic activity | |
| PL340400A1 (en) | 2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase | |
| IL132170A0 (en) | Novel heterocyclic compounds | |
| CZ220099A3 (en) | Novel compounds exhibiting analgetic activity | |
| GB9701684D0 (en) | Novel compounds | |
| PL337738A1 (en) | Novel substituted compounds of imidazole | |
| PL338791A1 (en) | Compounds exhibiting neuronic activity | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| IL125840A0 (en) | Production of bromine compounds | |
| PL327732A1 (en) | Compounds of therapeutic activity | |
| GB9701674D0 (en) | Use of organic compounds | |
| ZA981920B (en) | Novel heterocyclic compounds | |
| PL327538A1 (en) | Novel compounds of analgesic activity | |
| GB9726695D0 (en) | Novel compounds | |
| PL339673A1 (en) | Novel compounds suitable for use as neuroprotective agents | |
| ZA985448B (en) | Novel heterocyclic compounds | |
| HU9700442D0 (en) | Compounds of pharmaceutical activity | |
| ZA983800B (en) | Novel heterocyclic compounds | |
| GB9722026D0 (en) | Use of compounds | |
| SI1121108T1 (en) | Novel therapeutic use of compounds with beta-3-agonist activity | |
| ZA985449B (en) | Novel heterocyclic compounds | |
| HU9701917D0 (en) | New compound of medicinal activity |